Related Experiment Video

Updated: Jun 20, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Antitumoractive endoperoxides from triterpenes

Anja Niesen1, Alexander Barthel, Ralph Kluge

  • 1Martin-Luther-Universität Halle-Wittenberg, Organische Chemie, Halle (Saale), Germany.

Archiv Der Pharmazie
|August 26, 2009
PubMed

Insights

New triterpene endoperoxides demonstrate potent antitumor capabilities. These compounds effectively induce apoptosis, offering promising results against various human cancers.

Area of Science:

  • Organic Chemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Triterpene endoperoxides represent a class of natural products with diverse biological activities.
  • Identifying novel compounds with potent anticancer effects is crucial for therapeutic development.

Purpose of the Study:

  • To synthesize a series of novel triterpene endoperoxides.
  • To evaluate the antitumor activity of these synthesized compounds against a panel of human cancer cell lines.

Main Methods:

  • Chemical synthesis of triterpene endoperoxide analogues.
  • Antitumor activity screening using the sulforhodamine-B (SRB) assay.
  • Assessment of apoptosis induction in cancer cells.

Main Results:

  • The synthesized triterpene endoperoxides exhibited significant antitumor activity across 15 human cancer cell lines.
  • Compounds were found to effectively induce apoptosis, a key mechanism in cancer cell death.
  • The structure-activity relationship indicated promising leads for further drug development.

Conclusions:

  • The novel triterpene endoperoxides possess excellent potential as anticancer agents.
  • Apoptosis induction is a primary mechanism underlying their observed antitumor effects.
  • Further investigation is warranted to explore their therapeutic applications in oncology.

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.